CD36 and neoplasm: Drivers of this metabolic profile shift include tumor-derived cytokines (e.g., G-CSF and GM-CSF) that signal through STAT3 and STAT5 pathways to upregulate CD36, a fatty acid transporter (Al-Khami et al., 2017).